Advancing Oncology & Specialty Care Through Global Partnerships
Uniphar Pakistan imports high-quality oncology medicines from trusted international manufacturers, exports pharmaceutical products to international markets, and distributes the products of local pharmaceutical companies to healthcare institutions across Pakistan.
Three business lines, one specialty-pharma platform
From importing oncology medicines to exporting pharmaceutical products and distributing for local manufacturers — we connect quality medicines with the patients and institutions that need them.
Oncology Imports
We import high-quality oncology medicines from trusted international manufacturers — including our Argentine partners Varifarma and Kemex — for patients, hospitals and institutions across Pakistan.
- Oncology injectables & oral therapies
- Onco-hematology & supportive care
- Selected biosimilars
Pharmaceutical Exports
We export pharmaceutical products to international markets across the GCC, Central Asia, Africa and Asia, building registrations and distributor partnerships market by market.
- Partner & distributor development
- Registration in destination markets
- Tender & institutional business
Local Distribution
We distribute the products of established local pharmaceutical companies to government institutions, public-sector healthcare organizations and other healthcare institutions.
- Government & institutional supply
- Tender participation
- Supply planning & continuity
Specialty Medicines. Strategic Partnerships. Better Access.
Uniphar Pakistan is a pharmaceutical business focused on building access to high-quality specialty medicines, with a strategic emphasis on oncology, biosimilars and complex therapies.
We are an importer of oncology products, an exporter of pharmaceutical products and a distribution partner for local pharmaceutical companies. Our strategy is centered on bringing quality-driven therapies to markets where access, affordability and reliable supply matter. Through strategic partnerships with Varifarma and Kemex, both Argentina-based pharmaceutical companies, Uniphar is developing a differentiated portfolio across oncology and complex therapies.
More about Uniphar Pakistan- Oncology medicines and supportive care
- Selected biosimilars and complex biologic opportunities
- Specialty pharmaceuticals and hospital products
- International licensing and commercialization partnerships
- Regulatory registration and market access
- Commercialization, distribution and market development
Where we concentrate our expertise
We build portfolios around high-need therapeutic areas rather than pursuing a broad, undifferentiated generic portfolio.
Oncology
Established chemotherapy, targeted therapies, onco-hematology and supportive care.
Learn more Growth areaBiosimilars & Complex Biologics
Oncology biosimilars, monoclonal antibodies and high-value complex molecules.
Learn more SelectiveSpecialty Pharmaceuticals
Differentiated specialty and hospital medicines with meaningful healthcare impact.
Learn moreUniphar Pakistan × Varifarma × Kemex
Combining international product and manufacturing capabilities with Uniphar’s market development, regulatory and commercialization capabilities.
Experience that turns opportunities into sustainable businesses
Business development
Deep pharmaceutical business-development experience.
Regulatory insight
International market and regulatory understanding.
Manufacturing access
Access to specialized international manufacturing partners.
Commercial execution
Commercial execution and distributor development.
Portfolio building
Portfolio building with a long-term market perspective.
Institutional supply
Commercial operations and institutional supply.
An integrated pharmaceutical model
We participate in building pharmaceutical businesses — not simply providing reports.
- Step 1
Identify
Identify products, technologies and market opportunities aligned with our strategic focus.
- Step 2
Evaluate
Assess scientific, regulatory, manufacturing and commercial feasibility.
- Step 3
Partner
Establish licensing, supply, distribution or strategic partnership arrangements.
- Step 4
Register
Execute regulatory submissions and market-access requirements.
- Step 5
Launch
Build the commercial plan, channel strategy and launch execution.
- Step 6
Scale
Expand products, indications and geographies through disciplined portfolio management.
A recognized specialty-pharma platform for Pakistan and beyond
To build Uniphar Pakistan into a recognized specialty-pharma platform serving oncology and complex therapeutic needs through trusted global partnerships, strong regulatory standards and disciplined commercial execution.
Why partner with UnipharExplore a Partnership
Let’s build the next generation of specialty pharmaceutical opportunities together.